Hojná Silvie, Kadlecová Michaela, Dobesová Zdenka, Valousková Vera, Zicha Josef, Kunes Jaroslav
Institute of Physiology AS CR, Charles University, Videnska 1083, 142 20, Prague 4, Czech Republic.
Mol Cell Biochem. 2007 Mar;297(1-2):21-9. doi: 10.1007/s11010-006-9318-0. Epub 2006 Sep 29.
Increased blood pressure (BP) in genetic hypertension is usually caused by high activity of sympathetic nervous system (SNS) which is enhanced by central angiotensin II but lowered by central nitric oxide (NO). We have therefore evaluated NO synthase (NOS) activity as well as neuronal NOS (nNOS), inducible NOS (iNOS) and endothelial NOS (eNOS) protein expression in brainstem and midbrain of adult spontaneously hypertensive rats (SHR) characterized by enhanced sympathetic vasoconstriction. We also studied possible participation of brain NO in antihypertensive effects of chronic captopril treatment of adult SHR. NOS activity was increased in midbrain of SHR compared to Wistar-Kyoto (WKY) rats. This could be ascribed to enhanced iNOS expression, whereas nNOS expression was unchanged and eNOS expression was reduced in this brain region. In contrast, no significant changes of NOS activity were found in brainstem of SHR in which nNOS and iNOS expression was unchanged, but eNOS expression was increased. Chronic captopril administration lowered BP of adult SHR mainly by attenuation of sympathetic tone, whereas the reduction of angiotensin II-dependent vasoconstriction and the decrease of residual BP (amelioration of structural remodeling of resistance vessels) were less important. This treatment did not affect significantly either NOS activity or expression of any NOS isoform in the two brain regions. Our data do not support the hypothesis that altered brain NO formation contributes to sympathetic hyperactivity and high BP of adult SHR with established hypertension.
遗传性高血压中血压升高通常是由交感神经系统(SNS)活性增强引起的,中枢血管紧张素II可增强该系统活性,而中枢一氧化氮(NO)则可降低其活性。因此,我们评估了成年自发性高血压大鼠(SHR)脑干和中脑中一氧化氮合酶(NOS)的活性以及神经元型NOS(nNOS)、诱导型NOS(iNOS)和内皮型NOS(eNOS)的蛋白表达,这些大鼠的特点是交感神经血管收缩增强。我们还研究了脑内NO在成年SHR慢性卡托普利治疗的降压作用中可能发挥的作用。与Wistar-Kyoto(WKY)大鼠相比,SHR中脑的NOS活性增加。这可能归因于iNOS表达增强,而该脑区的nNOS表达未改变,eNOS表达减少。相反,在SHR的脑干中未发现NOS活性有显著变化,其中nNOS和iNOS表达未改变,但eNOS表达增加。慢性给予卡托普利主要通过减弱交感神经张力降低成年SHR的血压,而依赖血管紧张素II的血管收缩的降低和残余血压的下降(阻力血管结构重塑的改善)则不太重要。该治疗对这两个脑区的NOS活性或任何NOS同工型的表达均无显著影响。我们的数据不支持这样的假说,即脑内NO生成改变导致成年SHR已确立高血压时的交感神经过度活跃和高血压。